Next Article in Journal
Recent Approaches for the Topical Treatment of Psoriasis Using Nanoparticles
Previous Article in Journal
Impact of Drug-Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Alhasso et al. Development of a Nanoemulgel for the Topical Application of Mupirocin. Pharmaceutics 2023, 15, 2387

by
Bahjat Alhasso
1,
Muhammad Usman Ghori
1,
Simon P. Rout
1,2 and
Barbara R. Conway
1,3,*
1
Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK
2
Department of Biological and Geographical Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK
3
Institute of Skin Integrity and Infection Prevention, University of Huddersfield, Huddersfield HD1 3DH, UK
*
Author to whom correspondence should be addressed.
Pharmaceutics 2024, 16(4), 448; https://doi.org/10.3390/pharmaceutics16040448
Submission received: 21 February 2024 / Accepted: 23 February 2024 / Published: 25 March 2024
(This article belongs to the Section Nanomedicine and Nanotechnology)

Addition of an Author

Simon P. Rout was not included as an author in the original publication [1]. In addition to affiliation 1, Simon P. Rout’s affiliations should include: 2 Department of Biological and Geographical Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK. The corrected Author Contributions statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Author Contributions: Conceptualization, B.R.C.; Methodology, B.A., M.U.G., S.P.R. and B.R.C.; Validation, B.A.; Formal analysis, B.A.; Investigation, B.A. and S.P.R.; Data curation, B.A.; Writing—original draft, B.A.; Writing—review and editing, B.R.C.; Supervision, M.U.G. and B.R.C.; Project administration, B.R.C. All authors have read and agreed to the published version of the manuscript.

Reference

  1. Alhasso, B.; Ghori, M.U.; Rout, S.P.; Conway, B.R. Development of a Nanoemulgel for the Topical Application of Mupirocin. Pharmaceutics 2023, 15, 2387. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Alhasso, B.; Ghori, M.U.; Rout, S.P.; Conway, B.R. Correction: Alhasso et al. Development of a Nanoemulgel for the Topical Application of Mupirocin. Pharmaceutics 2023, 15, 2387. Pharmaceutics 2024, 16, 448. https://doi.org/10.3390/pharmaceutics16040448

AMA Style

Alhasso B, Ghori MU, Rout SP, Conway BR. Correction: Alhasso et al. Development of a Nanoemulgel for the Topical Application of Mupirocin. Pharmaceutics 2023, 15, 2387. Pharmaceutics. 2024; 16(4):448. https://doi.org/10.3390/pharmaceutics16040448

Chicago/Turabian Style

Alhasso, Bahjat, Muhammad Usman Ghori, Simon P. Rout, and Barbara R. Conway. 2024. "Correction: Alhasso et al. Development of a Nanoemulgel for the Topical Application of Mupirocin. Pharmaceutics 2023, 15, 2387" Pharmaceutics 16, no. 4: 448. https://doi.org/10.3390/pharmaceutics16040448

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop